MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Aurothiomalate sodium

CAS No. : 12244-57-4

MCE 站：Aurothiomalate sodium

产品活性：Aurothiomalate sodium 是一种有效的和选择性的致癌 PKC_ι 信号传导抑制剂。Aurothiomalate sodium 抑制肿瘤细胞增殖，而不抑制细胞凋亡。Aurothiomalate sodium 是一种有效的硫氧还蛋白还原酶 (TrxR) 抑制剂。Aurothiomalate sodium 是一种抗风湿剂，显示出有效的抗肿瘤活性。

研究领域：Epigenetics  |  TGF-beta/Smad

作用靶点：PKC

In Vitro: Aurothiomalate sodium (0.001, 0.01, 0.1, 1, 10, 100, 1000 uM) induces dose-dependent inhibition of anchorage-independent growth in all cell lines tested (A549, H1437, H2170, H460, H510, H187, H1703 and A427 lung cancer cell lines) with IC₅₀s ranging from 300 nM-107 ?M. The lung adenocarcinoma (LAC) and small cell lung carcinoma (SCLC) cells tends to be more sensitive and lung adenocarcinomas (LACs) less sensitive to Aurothiomalate sodium.
Aurothiomalate sodium (25 uM; 6 hours) suppresses TNFa-induced activation of NF-kB and the expression of NF-kB-targeted proinflammatory genes such as E-selectin and cyclooxygenase-2.
Aurothiomalate sodium inhibits non-small lung cancer (NSCLC) growth by binding PKC_ι and blocking activation of a PKC_ι-Par6-Rac1-Pak-Mek 1,2-Erk 1,2 signaling pathway.
Aurothiomalate sodium inhibits Mek/Erk signaling and decreases proliferative index without effecting tumor apoptosis or vascularization in vivo.

In Vivo: Aurothiomalate sodium (2, 6, 20 or 60 mg/kg/day; intramuscular injections; 40 days) exhibits statistically significant inhibition of tumor growth at all concentrations tested in A427 cell tumors because A427 cells are highly responsive.
Aurothiomalate sodium (20, 60 mg/kg/day; intramuscular injections; 15 days) shows a statistically significant response (~50% reduction in tumor size) only at the 60 mg/kg dose in H460 tumors because H460 cells are less responsive.
Aurothiomalate sodium (60 mg/kg/day; IP; for six weeks) exhibites a decrease in tumor growth in Three-week-old KrasLA2 mice. Aurothiomalate sodium inhibits Kras-mediated bronchioalveolar stem cells (BASCs) expansion and lung tumorigenesis in vivo.

相关产品：Phorbol 12-myristate 13-acetate  |  Staurosporine  |  Ionomycin  |  Go 6983  |  Midostaurin  |  Bisindolylmaleimide I  |  Fasudil Hydrochloride  |  Mitoxantrone  |  Rottlerin  |  Enzastaurin  |  Chelerythrine chloride  |  Ingenol Mebutate  |  Ro 31-8220 mesylate  |  K-252a  |  CGP60474  |  D-erythro-Sphingosine  |  Phorbol 12,13-dibutyrate  |  Verbascoside  |  Ruboxistaurin hydrochloride  |  (-)-Indolactam V  |  CMPD101  |  Daphnetin  |  DCP-LA  |  Go6976  |  BJE6-106  |  Decursin  |  Valrubicin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。